Cargando…

A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function

Heart Failure with preserved Ejection Fraction (HFpEF) represents a major public health problem. The causative mechanisms are multifactorial and there are no effective treatments for HFpEF, partially attributable to the lack of well-established HFpEF animal models. We established a feline HFpEF mode...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallner, Markus, Eaton, Deborah M., Berretta, Remus M., Borghetti, Giulia, Wu, Jichuan, Baker, Sandy T., Feldsott, Eric A., Sharp, Thomas E., Mohsin, Sadia, Oyama, Mark A., von Lewinski, Dirk, Post, Heiner, Wolfson, Marla R., Houser, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707379/
https://www.ncbi.nlm.nih.gov/pubmed/29185443
http://dx.doi.org/10.1038/s41598-017-15851-2
_version_ 1783282406630883328
author Wallner, Markus
Eaton, Deborah M.
Berretta, Remus M.
Borghetti, Giulia
Wu, Jichuan
Baker, Sandy T.
Feldsott, Eric A.
Sharp, Thomas E.
Mohsin, Sadia
Oyama, Mark A.
von Lewinski, Dirk
Post, Heiner
Wolfson, Marla R.
Houser, Steven R.
author_facet Wallner, Markus
Eaton, Deborah M.
Berretta, Remus M.
Borghetti, Giulia
Wu, Jichuan
Baker, Sandy T.
Feldsott, Eric A.
Sharp, Thomas E.
Mohsin, Sadia
Oyama, Mark A.
von Lewinski, Dirk
Post, Heiner
Wolfson, Marla R.
Houser, Steven R.
author_sort Wallner, Markus
collection PubMed
description Heart Failure with preserved Ejection Fraction (HFpEF) represents a major public health problem. The causative mechanisms are multifactorial and there are no effective treatments for HFpEF, partially attributable to the lack of well-established HFpEF animal models. We established a feline HFpEF model induced by slow-progressive pressure overload. Male domestic short hair cats (n = 20), underwent either sham procedures (n = 8) or aortic constriction (n = 12) with a customized pre-shaped band. Pulmonary function, gas exchange, and invasive hemodynamics were measured at 4-months post-banding. In banded cats, echocardiography at 4-months revealed concentric left ventricular (LV) hypertrophy, left atrial (LA) enlargement and dysfunction, and LV diastolic dysfunction with preserved systolic function, which subsequently led to elevated LV end-diastolic pressures and pulmonary hypertension. Furthermore, LV diastolic dysfunction was associated with increased LV fibrosis, cardiomyocyte hypertrophy, elevated NT-proBNP plasma levels, fluid and protein loss in pulmonary interstitium, impaired lung expansion, and alveolar-capillary membrane thickening. We report for the first time in HFpEF perivascular fluid cuff formation around extra-alveolar vessels with decreased respiratory compliance. Ultimately, these cardiopulmonary abnormalities resulted in impaired oxygenation. Our findings support the idea that this model can be used for testing novel therapeutic strategies to treat the ever growing HFpEF population.
format Online
Article
Text
id pubmed-5707379
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57073792017-12-06 A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function Wallner, Markus Eaton, Deborah M. Berretta, Remus M. Borghetti, Giulia Wu, Jichuan Baker, Sandy T. Feldsott, Eric A. Sharp, Thomas E. Mohsin, Sadia Oyama, Mark A. von Lewinski, Dirk Post, Heiner Wolfson, Marla R. Houser, Steven R. Sci Rep Article Heart Failure with preserved Ejection Fraction (HFpEF) represents a major public health problem. The causative mechanisms are multifactorial and there are no effective treatments for HFpEF, partially attributable to the lack of well-established HFpEF animal models. We established a feline HFpEF model induced by slow-progressive pressure overload. Male domestic short hair cats (n = 20), underwent either sham procedures (n = 8) or aortic constriction (n = 12) with a customized pre-shaped band. Pulmonary function, gas exchange, and invasive hemodynamics were measured at 4-months post-banding. In banded cats, echocardiography at 4-months revealed concentric left ventricular (LV) hypertrophy, left atrial (LA) enlargement and dysfunction, and LV diastolic dysfunction with preserved systolic function, which subsequently led to elevated LV end-diastolic pressures and pulmonary hypertension. Furthermore, LV diastolic dysfunction was associated with increased LV fibrosis, cardiomyocyte hypertrophy, elevated NT-proBNP plasma levels, fluid and protein loss in pulmonary interstitium, impaired lung expansion, and alveolar-capillary membrane thickening. We report for the first time in HFpEF perivascular fluid cuff formation around extra-alveolar vessels with decreased respiratory compliance. Ultimately, these cardiopulmonary abnormalities resulted in impaired oxygenation. Our findings support the idea that this model can be used for testing novel therapeutic strategies to treat the ever growing HFpEF population. Nature Publishing Group UK 2017-11-29 /pmc/articles/PMC5707379/ /pubmed/29185443 http://dx.doi.org/10.1038/s41598-017-15851-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Wallner, Markus
Eaton, Deborah M.
Berretta, Remus M.
Borghetti, Giulia
Wu, Jichuan
Baker, Sandy T.
Feldsott, Eric A.
Sharp, Thomas E.
Mohsin, Sadia
Oyama, Mark A.
von Lewinski, Dirk
Post, Heiner
Wolfson, Marla R.
Houser, Steven R.
A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
title A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
title_full A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
title_fullStr A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
title_full_unstemmed A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
title_short A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function
title_sort feline hfpef model with pulmonary hypertension and compromised pulmonary function
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707379/
https://www.ncbi.nlm.nih.gov/pubmed/29185443
http://dx.doi.org/10.1038/s41598-017-15851-2
work_keys_str_mv AT wallnermarkus afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT eatondeborahm afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT berrettaremusm afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT borghettigiulia afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT wujichuan afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT bakersandyt afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT feldsotterica afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT sharpthomase afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT mohsinsadia afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT oyamamarka afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT vonlewinskidirk afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT postheiner afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT wolfsonmarlar afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT houserstevenr afelinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT wallnermarkus felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT eatondeborahm felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT berrettaremusm felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT borghettigiulia felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT wujichuan felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT bakersandyt felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT feldsotterica felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT sharpthomase felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT mohsinsadia felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT oyamamarka felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT vonlewinskidirk felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT postheiner felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT wolfsonmarlar felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction
AT houserstevenr felinehfpefmodelwithpulmonaryhypertensionandcompromisedpulmonaryfunction